Latest filing published 15 Jun 2026 for Metis TechBio Co., Ltd. - P - H Shares.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Chen Hongming: trading record in brief
Chen Hongming discloses dealings in 2 companies, chiefly KALA BIO, Inc. and Metis TechBio Co., Ltd. - P - H Shares. Between 28 February 2018 and 10 June 2026, the trades on record add up to 13 filings.
No open-market purchase appears, only 4 sales worth €85k. Besides market trades, the filings include 3 share grants and 5 option exercises.
Most recently, on 15 June 2026, the filings show a transaction in Metis TechBio Co., Ltd. - P - H Shares. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Chen Hongming
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 46,839,443 sharesShareXHKGHKEX:DA20260615E00269
- 9,449 shares@ US$1.8028.0% of flowCommon StockSEC:0001415889-21-005014:0
- 5,548 shares@ US$5.5649.4% of flowCommon StockSEC:0001415889-21-003271:0
- 2,452 shares@ US$5.7722.6% of flowCommon StockSEC:0001415889-21-003261:0
4 of 4 declarations